Sign up

Nantahala Capital Management, LLC

$1.7B assets · 132 holdings · Q2 2026 · Filed 19 AUG 2026

About Nantahala Capital Management, LLC’s 13F portfolio

Nantahala Capital Management, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Nantahala Capital Management, LLC reported $1.7B across 132 US-listed positions (). Its largest position is BANCORP INC DEL (TBBK) at 4.7% of the reported book, and its ten biggest holdings make up 27% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$1.7B
Assets (13F)
#1,705
of 8,845 by size
132
Holdings
27%
Top-10 weight
47
Buys
59
Sells
Top holdings · Q2 2026
132 total
#StockPrice% of portfolioSharesValue
1
NASDAQ: TBBK
BANCORP INC DEL
$44.26
−1.97%
4.7%
1.2M$77.7M
2
NASDAQ: BVS
BIOVENTUS INC
$9.95
−6.31%
3.4%
6.0M$56.6M
3
NYSE: HGV
HILTON GRAND VACATIONS INC
$44.65
−3.88%
3.3%
1.0M$54.1M
4
NASDAQ: SVRA
SAVARA INC
$5.21
+10.38%
2.6%
7.0M$43.0M
5
NASDAQ: ETON
ETON PHARMACEUTICALS INC
$61.36
−1.02%
2.6%
1.2M$42.6M
6
NASDAQ: AMRX
AMNEAL PHARMACEUTICALS INC
$21.39
−2.24%
2.4%
2.3M$39.3M
7
NASDAQ: EOLS
EVOLUS INC
$7.00
−0.99%
2.3%
5.6M$38.9M
8
NASDAQ: AVTX
AVALO THERAPEUTICS INC
$6.75
+0.75%
2.1%
1.9M$34.4M
9
NASDAQ: LBRX
LB PHARMACEUTICALS INC
$40.04
−0.05%
2.1%
1.1M$34.2M
10
NASDAQ: AVR
ANTERIS TECHNOLOGIES GLOBAL
$5.09
−2.30%
2.0%
3.4M$33.3M
11
NASDAQ: ABEO
ABEONA THERAPEUTICS INC
$2.45
−10.26%
1.9%
5.1M$31.7M
12
NASDAQ: PTON
PELOTON INTERACTIVE INC
$5.07
−5.23%
1.8%
5.1M$30.2M
13
NASDAQ: ESTA
ESTABLISHMENT LABS HLDGS INC
$69.61
−1.68%
1.7%
336K$28.8M
14
NYSE American: XTNT
XTANT MED HLDGS INC
$0.22
+5.00%
1.7%
68.4M$28.8M
15
NASDAQ: JACK
JACK IN THE BOX INC
$13.80
−6.69%
1.7%
1.7M$27.3M
16
NASDAQ: GOGO
GOGO INC
$2.78
−5.12%
1.6%
8.7M$27.0M
17
NYSE: IMAX
IMAX CORP
$46.18
−1.30%
1.6%
658K$26.2M
18
NASDAQ: ZVRA
ZEVRA THERAPEUTICS INC
$9.07
−2.26%
1.6%
1.8M$25.8M
19
NASDAQ: TITN
TITAN MACHY INC
$20.77
−2.53%
1.4%
1.1M$23.9M
20
NASDAQ: RMR
RMR GROUP INC
$16.33
−4.00%
1.4%
1.1M$23.6M
21
NASDAQ: FOSL
FOSSIL GROUP INC
$7.60
−8.65%
1.4%
5.5M$22.8M
22
NASDAQ: FOXF
FOX FACTORY HLDG CORP
$16.90
−1.97%
1.3%
1.3M$22.2M
23
NASDAQ: MLYS
MINERALYS THERAPEUTICS INC
$14.16
+2.76%
1.3%
820K$22.1M
24
NASDAQ: RDNW
RIDENOW GROUP INC
$4.42
−1.67%
1.3%
3.3M$21.8M
25
NASDAQ: QURE
UNIQURE NV
$20.23
−0.34%
1.3%
456K$21.0M

Showing 1–25 of 132 positions on this page reported in this 13F.

Sector allocation
  • Healthcare59%
  • Consumer Cyclical16%
  • Financial Services6.2%
  • Communication Services4.1%
  • Industrials3.0%
  • Real Estate2.6%
  • Consumer Defensive2.4%
  • Technology1.6%
  • Basic Materials0.8%
Recent activity · vs 2026-03-31
Bought47
  • AddedAVTXAVALO THERAPEUTICS INC+50.8%$34.4M
  • AddedABEOABEONA THERAPEUTICS INC+2.5%$31.7M
  • AddedJACKJACK IN THE BOX INC+12.1%$27.3M
  • AddedIMAXIMAX CORP+27.6%$26.2M
  • AddedFOSLFOSSIL GROUP INC+1.9%$22.8M
  • AddedQUREUNIQURE NV+92.2%$21.0M
  • AddedAURAAURA BIOSCIENCES INC+39.4%$21.0M
  • AddedAGMBAGOMAB THERAPEUTICS NV+30.7%$20.4M
  • AddedFULCFULCRUM THERAPEUTICS INC+79.5%$20.0M
  • AddedBNTCBENITEC BIOPHARMA INC+3.5%$19.9M
Sold59
  • ReducedTBBKBANCORP INC DEL−10.2%$77.7M
  • ReducedBVSBIOVENTUS INC−2.0%$56.6M
  • ReducedHGVHILTON GRAND VACATIONS INC−31.7%$54.1M
  • ReducedSVRASAVARA INC−5.0%$43.0M
  • ReducedAMRXAMNEAL PHARMACEUTICALS INC−20.2%$39.3M
  • ReducedEOLSEVOLUS INC−12.2%$38.9M
  • ReducedAVRANTERIS TECHNOLOGIES GLOBAL−38.8%$33.3M
  • ReducedPTONPELOTON INTERACTIVE INC−57.4%$30.2M
  • ReducedESTAESTABLISHMENT LABS HLDGS INC−59.7%$28.8M
  • ReducedGOGOGOGO INC−2.1%$27.0M
5%+ Beneficial Ownership Stakes · 1 activist (13D) · 44 passive (13G)

Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.

#StockType% of classSharesFiled
1
—
Eagle Pharmaceuticals, Inc.
13G38.1%4.9MFiled 14 AUG 2025
2
TELA
TELA Bio, Inc.
13G14.5% · 2 classes6.5MFiled 13 NOV 2026
3
RACC
Research Alliance Corp III
13G14.1%1.1MFiled 07 OCT 2026
4
GUTS
Fractyl Health, Inc.
13G10.0% · 2 classes13.3MFiled 14 NOV 2025
5
COCH
ENVOY MEDICAL, INC.
13G10.0%7.7MFiled 15 MAY 2026
6
AZTR
AZITRA, INC.
13G10.0%6.5MFiled 14 AUG 2026
7
FOSL
FOSSIL GROUP, INC.
13G10.0% · 2 classes5.9MFiled 15 MAY 2026
8
ABEO
ABEONA THERAPEUTICS INC.
13G10.0% · 2 classes5.8MFiled 15 MAY 2026
9
QNCX
Quince Therapeutics, Inc.
13G10.0% · 2 classes5.6MFiled 14 NOV 2025
10
AEON
AEON Biopharma, Inc.
13G10.0%5.0MFiled 13 NOV 2026
11
ELUT
Elutia Inc.
13G10.0%4.1MFiled 13 FEB 2026
12
APYX
APYX MEDICAL CORPORATION
13G10.0%4.1MFiled 13 FEB 2026
13
UNCY
Unicycive Therapeutics, Inc.
13G10.0% · 2 classes2.8MFiled 14 AUG 2026
14
XFOR
X4 PHARMACEUTICALS, INC
13G10.0%2.2MFiled 14 NOV 2025
15
DRIO
DarioHealth Corp.
13G10.0% · 2 classes979KFiled 13 NOV 2026
16
EDSA
EDESA BIOTECH, INC.
13G10.0%856KFiled 13 FEB 2026
17
PHGE
BiomX Inc.
13G10.0% · 2 classes157KFiled 13 FEB 2026
18
ADCT
ADC Therapeutics SA
13G9.7%12.3MFiled 14 AUG 2026
19
AVTX
AVALO THERAPEUTICS, INC.
13G9.4%1.2MFiled 14 NOV 2025
20
ASRT
ASSERTIO HOLDINGS, INC.
13G9.4% · 2 classes8.9MFiled 14 NOV 2024
21
HAIN
The Hain Celestial Group, Inc.
13G9.4% · 2 classes8.5MFiled 15 MAY 2026
22
BVS
BIOVENTUS INC.
13G9.0%6.0MFiled 13 FEB 2026
23
EOLS
EVOLUS, INC.
13G8.8%5.7MFiled 14 NOV 2025
24
RDNW
RumbleOn, Inc.
13G8.7%3.1MFiled 14 NOV 2024
25
FULC
FULCRUM THERAPEUTICS, INC.
13G8.6% · 2 classes6.6MFiled 13 NOV 2026

Showing 1–25 of 45 disclosed stakes. 7 last disclosed over a year ago (the holder may since have dropped below 5%).

Reading Nantahala Capital Management, LLC’s 13F portfolio

Nantahala Capital Management, LLC’s $1.7B 13F book is spread across 132 reported positions and is moderately diversified, the ten largest names accounting for 27%. There are meaningful positions at the top alongside a long tail of smaller holdings. Its five largest positions are TBBK, BVS, HGV, SVRA and ETON, led by BANCORP INC DEL (TBBK) at 4.7% of the portfolio. The heaviest sector exposure is Healthcare (59%), then Consumer Cyclical (16%).

What Nantahala Capital Management, LLC changed last quarter

Between 2026-03-31 and Q2 2026, Nantahala Capital Management, LLC was a net seller: it opened 22 new positions and added to 25 more, while trimming 39 and closing 20 outright. Against a 132-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was AVALO THERAPEUTICS INC (AVTX), and its biggest reduction was BANCORP INC DEL (TBBK).

What a 13F does and doesn’t reveal

A 13F captures only Nantahala Capital Management, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Nantahala Capital Management, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Nantahala Capital Management, LLC's profile on this page is built directly from those filings.

How current is the 13F data on Nantahala Capital Management, LLC's page?

It reflects Nantahala Capital Management, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Nantahala Capital Management, LLC files its next quarterly report, this page refreshes automatically.

Can I see Nantahala Capital Management, LLC's complete list of holdings?

This page highlights Nantahala Capital Management, LLC's largest positions rather than all 132 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Nantahala Capital Management, LLC's filings.

Does a 13F show everything Nantahala Capital Management, LLC owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Nantahala Capital Management, LLC's book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Nantahala Capital Management, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.